Back to News
Market Impact: 0.25
Xenix Medical Announces FDA Clearance of the Riva® Anchor Spinopelvic Fixation System with NanoACTIV™ Surface Technology
Source: Business Wire
Healthcare & BiotechProduct LaunchesRegulation & LegislationTechnology & Innovation
Xenix Medical announced FDA clearance for its Riva Anchor Spinopelvic Fixation System featuring NanoACTIV Surface Technology. The clearance enables commercialization of the spinal fixation system in the U.S. and is a positive regulatory milestone for the company, though the release provides no financial projections or sales estimates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.60
More News
- Wall Street’s Nasdaq hits all-time high as AI frenzy gathers pace
- Data-Center Bet Makes ESDS One of India’s Best New Listings
- Asia stocks ride tech wave higher, oil stays subdued
- Trump Says US Team Met With Iranians at UNGA
- Paramount will need to release way more movies to make this merger work
- Sullivan: Wall Street admits it doesn't know where oil is headed. There's one stock they do agree on